Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 98 entries
Sorted by: Best Match Show Resources per page
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome.

Therapeutics and clinical risk management

Yang YM, Choi EJ.
PMID: 26366087
Ther Clin Risk Manag. 2015 Sep 01;11:1345-53. doi: 10.2147/TCRM.S89737. eCollection 2015.

BACKGROUND: Polycystic ovary syndrome (PCOS) is an endocrinopathy that affects approximately 10% of reproductive-aged women throughout their lives. Women with PCOS present with heterogeneous symptoms including ovulatory dysfunction, hyperandrogenism, and polycystic ovaries. Therefore, lifelong individualized management should be considered....

Cite
Yang YM, Choi EJ. Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome. Ther Clin Risk Manag. 2015;11:1345-53doi: 10.2147/TCRM.S89737.
Yang, Y. M., & Choi, E. J. (2015). Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome. Therapeutics and clinical risk management, 111345-53. https://doi.org/10.2147/TCRM.S89737
Yang, Young-Mo, and Choi, Eun Joo. "Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome." Therapeutics and clinical risk management vol. 11 (2015): 1345-53. doi: https://doi.org/10.2147/TCRM.S89737
Yang YM, Choi EJ. Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome. Ther Clin Risk Manag. 2015 Sep 01;11:1345-53. doi: 10.2147/TCRM.S89737. eCollection 2015. PMID: 26366087; PMCID: PMC4562722.
Copy Download .nbib Format: NLM
Effect of type of opponent on aggression in male mice with particular reference to studies with antihormones.

Behavioural processes

Martinez M, Simon VM, Castaño D, Brain PF.
PMID: 24925787
Behav Processes. 1989 Dec;20(1):125-37. doi: 10.1016/0376-6357(89)90018-1.

The potential influence of the type of opponent used in intermale aggression encounters to assess the actions of drugs was examined. Two experiments were carried out, one with the antiandrogen Cyproterone Acetate and the other with the antioestrogen CI-680...

Cite
Martinez M, Simon VM, Castaño D, et al. Effect of type of opponent on aggression in male mice with particular reference to studies with antihormones. Behav Processes. 1989;20(1):125-37doi: 10.1016/0376-6357(89)90018-1.
Martinez, M., Simon, V. M., Castaño, D., & Brain, P. F. (1989). Effect of type of opponent on aggression in male mice with particular reference to studies with antihormones. Behavioural processes, 20(1), 125-37. https://doi.org/10.1016/0376-6357(89)90018-1
Martinez, M, et al. "Effect of type of opponent on aggression in male mice with particular reference to studies with antihormones." Behavioural processes vol. 20,1 (1989): 125-37. doi: https://doi.org/10.1016/0376-6357(89)90018-1
Martinez M, Simon VM, Castaño D, Brain PF. Effect of type of opponent on aggression in male mice with particular reference to studies with antihormones. Behav Processes. 1989 Dec;20(1):125-37. doi: 10.1016/0376-6357(89)90018-1. PMID: 24925787.
Copy Download .nbib Format: NLM
Antirenotropic action of antiandrogens cyproterone acetate, casodex, flutamide and epitestosterone.

Endocrine regulations

Starka L, Broulik PD, Hampl R, Nedvidkova J, Hill M.
PMID: 10979040
Endocr Regul. 1996 Jun;30(2):93-97.

The antirenotropic activities of three antiandrogens which are frequently used in the clinical praxis (cyproterone acetate, flutamide and casodex) and of natural endogenous antiandrogen epitestosterone were compared. The substances were administered in oil intraperitoneally to intact male mice. The...

Cite
Starka L, Broulik PD, Hampl R, et al. Antirenotropic action of antiandrogens cyproterone acetate, casodex, flutamide and epitestosterone. Endocr Regul. 1996;30(2):93-97
Starka, L., Broulik, P. D., Hampl, R., Nedvidkova, J., & Hill, M. (1996). Antirenotropic action of antiandrogens cyproterone acetate, casodex, flutamide and epitestosterone. Endocrine regulations, 30(2), 93-97.
Starka, et al. "Antirenotropic action of antiandrogens cyproterone acetate, casodex, flutamide and epitestosterone." Endocrine regulations vol. 30,2 (1996): 93-97.
Starka L, Broulik PD, Hampl R, Nedvidkova J, Hill M. Antirenotropic action of antiandrogens cyproterone acetate, casodex, flutamide and epitestosterone. Endocr Regul. 1996 Jun;30(2):93-97. PMID: 10979040.
Copy Download .nbib Format: NLM
Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer.

The Canadian journal of urology

Trachtenberg J, Farival-Mohseni H, Jewett MA.
PMID: 12741967
Can J Urol. 1996 Sep;3(3):240-245.

The four antiandrogens currently available (cyproterone acetate, flutamide, nilutamide and bilcalutamide) are reviewed relative to their structure, pharmacology and clinical effect.

Cite
Trachtenberg J, Farival-Mohseni H, Jewett MA. Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer. Can J Urol. 1996;3(3):240-245
Trachtenberg, J., Farival-Mohseni, H., & Jewett, M. A. (1996). Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer. The Canadian journal of urology, 3(3), 240-245.
Trachtenberg, John, et al. "Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer." The Canadian journal of urology vol. 3,3 (1996): 240-245.
Trachtenberg J, Farival-Mohseni H, Jewett MA. Steroidal versus nonsteroidal antiandrogens in the management of prostate cancer. Can J Urol. 1996 Sep;3(3):240-245. PMID: 12741967.
Copy Download .nbib Format: NLM
Flare Associated with LHRH-Agonist Therapy.

Reviews in urology

Thompson IM.
PMID: 16986003
Rev Urol. 2001;3:S10-4.

The most common form of hormonal treatment for prostate cancer is luteinizing hormone-releasing hormone (LHRH)-agonist therapy. During the first 1 to 3 weeks of LHRH-agonist therapy, an initial increase in testosterone is associated with a condition known as "flare."...

Cite
Thompson IM. Flare Associated with LHRH-Agonist Therapy. Rev Urol. 2001;3:S10-4
Thompson, I. M. (2001). Flare Associated with LHRH-Agonist Therapy. Reviews in urology, 3S10-4.
Thompson, I M. "Flare Associated with LHRH-Agonist Therapy." Reviews in urology vol. 3 (2001): S10-4.
Thompson IM. Flare Associated with LHRH-Agonist Therapy. Rev Urol. 2001;3:S10-4. PMID: 16986003; PMCID: PMC1476081.
Copy Download .nbib Format: NLM
Sensitive detection of growth stimulating tumour promoters in perifused primary rat hepatocyte cultures.

Toxicology in vitro : an international journal published in association with BIBRA

Klein S, Gebhardt R.
PMID: 20654349
Toxicol In Vitro. 1997 Oct;11(5):543-7. doi: 10.1016/s0887-2333(97)00063-5.

Comparison of stationary cultivation with discrete changes of the medium with perifusion, where the hepatocytes are cultivated under a continuous flow of medium showed an enhanced sensitivity of perifused hepatocytes towards the mitogen cyproterone acetate (CPA) and the potential...

Cite
Klein S, Gebhardt R. Sensitive detection of growth stimulating tumour promoters in perifused primary rat hepatocyte cultures. Toxicol In Vitro. 1997;11(5):543-7doi: 10.1016/s0887-2333(97)00063-5.
Klein, S., & Gebhardt, R. (1997). Sensitive detection of growth stimulating tumour promoters in perifused primary rat hepatocyte cultures. Toxicology in vitro : an international journal published in association with BIBRA, 11(5), 543-7. https://doi.org/10.1016/s0887-2333(97)00063-5
Klein, S, and Gebhardt, R. "Sensitive detection of growth stimulating tumour promoters in perifused primary rat hepatocyte cultures." Toxicology in vitro : an international journal published in association with BIBRA vol. 11,5 (1997): 543-7. doi: https://doi.org/10.1016/s0887-2333(97)00063-5
Klein S, Gebhardt R. Sensitive detection of growth stimulating tumour promoters in perifused primary rat hepatocyte cultures. Toxicol In Vitro. 1997 Oct;11(5):543-7. doi: 10.1016/s0887-2333(97)00063-5. PMID: 20654349.
Copy Download .nbib Format: NLM
Specific binding of 11-ketotestosterone in an androgen target organ, the kidney of the male three-spined stickleback,Gasterosteus aculeatus.

Fish physiology and biochemistry

Jakobsson S, Mayer I, Schulz RW, Blankenstein MA, Borg B.
PMID: 24194355
Fish Physiol Biochem. 1996 Dec;15(6):459-67. doi: 10.1007/BF01874920.

The kidney of male three-spined stickleback,Gasterosteus aculeatus, hypertrophies during the breeding season and produces a "glue" which is used in the building of the nest. This hypertrophy is androgen dependent, with 11-ketotestosterone (11KT) being more effective than other tested...

Cite
Jakobsson S, Mayer I, Schulz RW, et al. Specific binding of 11-ketotestosterone in an androgen target organ, the kidney of the male three-spined stickleback,Gasterosteus aculeatus. Fish Physiol Biochem. 1996;15(6):459-67doi: 10.1007/BF01874920.
Jakobsson, S., Mayer, I., Schulz, R. W., Blankenstein, M. A., & Borg, B. (1996). Specific binding of 11-ketotestosterone in an androgen target organ, the kidney of the male three-spined stickleback,Gasterosteus aculeatus. Fish physiology and biochemistry, 15(6), 459-67. https://doi.org/10.1007/BF01874920
Jakobsson, S, et al. "Specific binding of 11-ketotestosterone in an androgen target organ, the kidney of the male three-spined stickleback,Gasterosteus aculeatus." Fish physiology and biochemistry vol. 15,6 (1996): 459-67. doi: https://doi.org/10.1007/BF01874920
Jakobsson S, Mayer I, Schulz RW, Blankenstein MA, Borg B. Specific binding of 11-ketotestosterone in an androgen target organ, the kidney of the male three-spined stickleback,Gasterosteus aculeatus. Fish Physiol Biochem. 1996 Dec;15(6):459-67. doi: 10.1007/BF01874920. PMID: 24194355.
Copy Download .nbib Format: NLM
The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning.

The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa

Lippi G, van Staden PJ.
PMID: 30263177
S Afr J Psychiatr. 2017 Mar 10;23:982. doi: 10.4102/sajpsychiatry.v23i0.982. eCollection 2017.

BACKGROUND: Cyproterone acetate (CPA) is a steroidal anti-androgenic medication used in the field of psychiatry for the treatment of paraphilic disorders, hypersexuality, and inappropriate sexual behaviour which may be present in patients with disorders such as mild and major...

Cite
Lippi G, van Staden PJ. The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning. S Afr J Psychiatr. 2017;23:982doi: 10.4102/sajpsychiatry.v23i0.982.
Lippi, G., & van Staden, P. J. (2017). The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa, 23982. https://doi.org/10.4102/sajpsychiatry.v23i0.982
Lippi, Gian, and van Staden, Paul J. "The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning." The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa vol. 23 (2017): 982. doi: https://doi.org/10.4102/sajpsychiatry.v23i0.982
Lippi G, van Staden PJ. The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning. S Afr J Psychiatr. 2017 Mar 10;23:982. doi: 10.4102/sajpsychiatry.v23i0.982. eCollection 2017. PMID: 30263177; PMCID: PMC6138062.
Copy Download .nbib Format: NLM
Spotlight on a New Heme Oxygenase Pathway: Testosterone-Induced Shifts in Cardiac Oxidant/Antioxidant Status.

Antioxidants (Basel, Switzerland)

Szabó R, Börzsei D, Kupai K, Hoffmann A, Gesztelyi R, Magyariné Berkó A, Varga C, Pósa A.
PMID: 31394727
Antioxidants (Basel). 2019 Aug 07;8(8). doi: 10.3390/antiox8080288.

A low testosterone level contributes to the development of oxidative damages; however, the cardiovascular effects of exogenous hormone therapy are not well elucidated. The aim of our work is to study the association of the testosterone level, antioxidant/oxidant system,...

Cite
Szabó R, Börzsei D, Kupai K, et al. Spotlight on a New Heme Oxygenase Pathway: Testosterone-Induced Shifts in Cardiac Oxidant/Antioxidant Status. Antioxidants (Basel). 2019;8(8)doi: 10.3390/antiox8080288.
Szabó, R., Börzsei, D., Kupai, K., Hoffmann, A., Gesztelyi, R., Magyariné Berkó, A., Varga, C., & Pósa, A. (2019). Spotlight on a New Heme Oxygenase Pathway: Testosterone-Induced Shifts in Cardiac Oxidant/Antioxidant Status. Antioxidants (Basel, Switzerland), 8(8), . https://doi.org/10.3390/antiox8080288
Szabó, Renáta, et al. "Spotlight on a New Heme Oxygenase Pathway: Testosterone-Induced Shifts in Cardiac Oxidant/Antioxidant Status." Antioxidants (Basel, Switzerland) vol. 8,8 (2019). doi: https://doi.org/10.3390/antiox8080288
Szabó R, Börzsei D, Kupai K, Hoffmann A, Gesztelyi R, Magyariné Berkó A, Varga C, Pósa A. Spotlight on a New Heme Oxygenase Pathway: Testosterone-Induced Shifts in Cardiac Oxidant/Antioxidant Status. Antioxidants (Basel). 2019 Aug 07;8(8). doi: 10.3390/antiox8080288. PMID: 31394727; PMCID: PMC6720826.
Copy Download .nbib Format: NLM
Is there a role for 5α-reductase inhibitors in transgender individuals?.

Andrology

Irwig MS.
PMID: 32749751
Andrology. 2021 Nov;9(6):1729-1731. doi: 10.1111/andr.12881. Epub 2020 Sep 02.

This commentary will explore the important clinical question regarding whether the antiandrogen class of 5α-reductase inhibitors should be considered as an effective and safe treatment option for transfeminine and/or transmasculine individuals. The use of finasteride in transfeminine individuals is...

Cite
Irwig MS. Is there a role for 5α-reductase inhibitors in transgender individuals?. Andrology. 2020;9(6):1729-1731doi: 10.1111/andr.12881.
Irwig, M. S. (2021). Is there a role for 5α-reductase inhibitors in transgender individuals?. Andrology, 9(6), 1729-1731. https://doi.org/10.1111/andr.12881
Irwig, Michael S. "Is there a role for 5α-reductase inhibitors in transgender individuals?." Andrology vol. 9,6 (2021): 1729-1731. doi: https://doi.org/10.1111/andr.12881
Irwig MS. Is there a role for 5α-reductase inhibitors in transgender individuals?. Andrology. 2021 Nov;9(6):1729-1731. doi: 10.1111/andr.12881. Epub 2020 Sep 02. PMID: 32749751.
Copy Download .nbib Format: NLM
Sorption, transport, and transformation of natural and synthetic progestins in soil-water systems.

Journal of hazardous materials

Yang X, Lin H, Dai X, Zhang Z, Gong B, Hu Z, Jiang X, Li Y.
PMID: 31668762
J Hazard Mater. 2020 Feb 15;384:121482. doi: 10.1016/j.jhazmat.2019.121482. Epub 2019 Oct 18.

Natural and synthetic progestins are emerging endocrine disruptors that can be transported from livestock farms and agricultural fields to receiving waters via surface runoff. The transformation of progestins during transport is expected to affect the efficiencies of runoff management...

Cite
Yang X, Lin H, Dai X, et al. Sorption, transport, and transformation of natural and synthetic progestins in soil-water systems. J Hazard Mater. 2019;384:121482doi: 10.1016/j.jhazmat.2019.121482.
Yang, X., Lin, H., Dai, X., Zhang, Z., Gong, B., Hu, Z., Jiang, X., & Li, Y. (2020). Sorption, transport, and transformation of natural and synthetic progestins in soil-water systems. Journal of hazardous materials, 384121482. https://doi.org/10.1016/j.jhazmat.2019.121482
Yang, Xingjian, et al. "Sorption, transport, and transformation of natural and synthetic progestins in soil-water systems." Journal of hazardous materials vol. 384 (2020): 121482. doi: https://doi.org/10.1016/j.jhazmat.2019.121482
Yang X, Lin H, Dai X, Zhang Z, Gong B, Hu Z, Jiang X, Li Y. Sorption, transport, and transformation of natural and synthetic progestins in soil-water systems. J Hazard Mater. 2020 Feb 15;384:121482. doi: 10.1016/j.jhazmat.2019.121482. Epub 2019 Oct 18. PMID: 31668762.
Copy Download .nbib Format: NLM
Influence of circulating testosterone concentration on sperm cryoresistance: The ibex as an experimental model.

Andrology

Bóveda P, Esteso MC, Velázquez R, Castaño C, Toledano-Díaz A, López-Sebastián A, Mejía O, Millán de la Blanca MG, Ungerfeld R, Santiago-Moreno J.
PMID: 33686789
Andrology. 2021 Jul;9(4):1242-1253. doi: 10.1111/andr.12998. Epub 2021 Mar 22.

BACKGROUND: Recent studies have noted that the circulating testosterone concentration may affect the ability of spermatozoa to survive cryopreservation. However, few attempts to confirm such a relationship have been made. Wild ruminant species have very marked seasonal changes in...

Cite
Bóveda P, Esteso MC, Velázquez R, et al. Influence of circulating testosterone concentration on sperm cryoresistance: The ibex as an experimental model. Andrology. 2021;9(4):1242-1253doi: 10.1111/andr.12998.
Bóveda, P., Esteso, M. C., Velázquez, R., Castaño, C., Toledano-Díaz, A., López-Sebastián, A., Mejía, O., Millán de la Blanca, M. G., Ungerfeld, R., & Santiago-Moreno, J. (2021). Influence of circulating testosterone concentration on sperm cryoresistance: The ibex as an experimental model. Andrology, 9(4), 1242-1253. https://doi.org/10.1111/andr.12998
Bóveda, Paula, et al. "Influence of circulating testosterone concentration on sperm cryoresistance: The ibex as an experimental model." Andrology vol. 9,4 (2021): 1242-1253. doi: https://doi.org/10.1111/andr.12998
Bóveda P, Esteso MC, Velázquez R, Castaño C, Toledano-Díaz A, López-Sebastián A, Mejía O, Millán de la Blanca MG, Ungerfeld R, Santiago-Moreno J. Influence of circulating testosterone concentration on sperm cryoresistance: The ibex as an experimental model. Andrology. 2021 Jul;9(4):1242-1253. doi: 10.1111/andr.12998. Epub 2021 Mar 22. PMID: 33686789.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 98 entries